Role of immunosuppressive therapy in rheumatic diseases concurrent with COVID-19 | Annals of the Rheumatic Diseases

Subscribe
Log In More

Log in via Institution
Log in via OpenAthens

Log in using your username and password
For personal accounts OR managers of institutional accounts

Username *

Password *

Forgot your log in details?Register a new account?
Forgot your user name or password?
Basket
Search More

Search for this keyword

Advanced search

Close More
Main menu

Latest content

Current issue

Archive

Authors

About

Podcasts
Subscribe
Log in More

Log in via Institution
Log in via OpenAthens

Log in using your username and password
For personal accounts OR managers of institutional accounts

Username *

Password *

Forgot your log in details?Register a new account?
Forgot your user name or password?
BMJ Journals

Article metrics

Viewpoint

Role of immunosuppressive therapy in rheumatic diseases concurrent with COVID-19

Online download statistics by month:

Online download statistics by month: April 2020 to March 2024

	Abstract	Full	Pdf
Apr 2020	1396	1259	1138
May 2020	1010	1024	673
Jun 2020	469	429	346
Jul 2020	272	234	172
Aug 2020	178	156	112
Sep 2020	220	185	90
Oct 2020	195	200	98
Nov 2020	146	124	78
Dec 2020	136	114	53
Jan 2021	163	144	73
Feb 2021	131	109	77
Mar 2021	143	113	81
Apr 2021	82	58	66
May 2021	112	89	57
Jun 2021	165	143	47
Jul 2021	77	71	35
Aug 2021	98	87	39
Sep 2021	95	84	42
Oct 2021	129	100	57
Nov 2021	78	66	40
Dec 2021	83	71	29
Jan 2022	104	90	43
Feb 2022	97	79	29
Mar 2022	100	78	38
Apr 2022	101	96	38
May 2022	84	80	39
Jun 2022	97	76	35
Jul 2022	60	52	20
Aug 2022	88	79	17
Sep 2022	106	96	28
Oct 2022	78	72	19
Nov 2022	80	72	19
Dec 2022	106	95	20
Jan 2023	86	74	24
Feb 2023	137	118	13
Mar 2023	71	62	27
Apr 2023	154	10	9
May 2023	171	13	7
Jun 2023	119	9	6
Jul 2023	115	5	4
Aug 2023	106	7	6
Sep 2023	228	1	5
Oct 2023	475	4	4
Nov 2023	670	7	3
Dec 2023	79	4	12
Jan 2024	37	2	29
Feb 2024	141	2	7
Mar 2024	109	5	13
Total	9177	6148	3917